Syros(SYRS) - 2022 Q3 - Earnings Call Transcript

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Karen Hunady - Director-Corporate Communications & Investor Relations Nancy Simonian - President & Chief Executive Officer David Roth - Chief Medical Officer Jason Haas - Chief Financial Officer Conference Call Participants Edward Tenthoff - Piper Sandler Philip Nadeau - Cowen Operator Good day, and welcome to the Q3 2022 Syros Pharmaceuticals, Inc. Earnings Conference Call. At this t ...